State Street’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-312,030
Closed -$181K 4360
2024
Q3
$181K Sell
312,030
-17,800
-5% -$9.98K ﹤0.01% 3843
2024
Q2
$204K Sell
329,830
-1,470,445
-82% -$1.24M ﹤0.01% 3823
2024
Q1
$4.63M Buy
1,800,275
+19,272
+1% +$47.1K ﹤0.01% 2962
2023
Q4
$3.63M Buy
1,781,003
+184,386
+12% +$337K ﹤0.01% 3095
2023
Q3
$2.75M Buy
1,596,617
+84,280
+6% +$150K ﹤0.01% 3192
2023
Q2
$2.95M Buy
1,512,337
+1,239,007
+453% +$2.9M ﹤0.01% 3236
2023
Q1
$760K Sell
273,330
-7,000
-2% -$20K ﹤0.01% 3614
2022
Q4
$967K Buy
280,330
+76,800
+38% +$219K ﹤0.01% 3564
2022
Q3
$523K Sell
203,530
-54,300
-21% -$173K ﹤0.01% 3764
2022
Q2
$624K Sell
257,830
-712,152
-73% -$1.87M ﹤0.01% 3750
2022
Q1
$4M Sell
969,982
-2,703,797
-74% -$14.3M ﹤0.01% 3289
2021
Q4
$47.2M Buy
3,673,779
+2,912,305
+382% +$32.2M ﹤0.01% 1842
2021
Q3
$8.22M Buy
761,474
+163,833
+27% +$1.49M ﹤0.01% 2988
2021
Q2
$5.46M Buy
597,641
+53,519
+10% +$495K ﹤0.01% 3203
2021
Q1
$5.13M Buy
544,122
+29,240
+6% +$403K ﹤0.01% 3041
2020
Q4
$2.03M Buy
514,882
+10,504
+2% +$31.8K ﹤0.01% 3372
2020
Q3
$1.34M Buy
504,378
+10,862
+2% +$40.3K ﹤0.01% 3347
2020
Q2
$3.28M Buy
493,516
+24,404
+5% +$164K ﹤0.01% 2975
2020
Q1
$2.73M Sell
469,112
-838
-0.2% -$7.04K ﹤0.01% 2922
2019
Q4
$4.21M Buy
469,950
+28,938
+7% +$241K ﹤0.01% 2916
2019
Q3
$3.81M Buy
441,012
+89,982
+26% +$909K ﹤0.01% 2926
2019
Q2
$3.91M Buy
351,030
+240,315
+217% +$2.75M ﹤0.01% 2958
2019
Q1
$1.47M Buy
110,715
+49,555
+81% +$662K ﹤0.01% 3253
2018
Q4
$945K Buy
+61,160
New +$1.17M ﹤0.01% 3339

Other funds holding GRTS

State Street's GRTS Position: Q4 2024 in Review

State Street sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 312,030 shares — an estimated $181K sold.

State Street first reported a position in GRTS in Q4 2018 and held it in 24 quarters. The position peaked at $47.2M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • State Street reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • State Street sold 312,030 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $181K.
  • State Street first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • State Street's Gritstone bio, Inc. Common Stock position peaked at $47.2M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on State Street's 13F filing for Q4 2024, filed 14 Feb 2025.